Article

House Report Blames Strict FDA for Drug Scarcity

Overly stringent enforcement by health regulators has caused the majority of drug shortages in the United States, according to a new report from a Republican-led House of Representatives committee.

The House Committee on Oversight and Government Reform said U.S. Food and Drug Administration inspections have forced four top generic drugmakers to shut down 30 percent of their manufacturing capacity, throwing the nation's drug supply into disarray.

Responding to the report, the FDA said preventing drug shortages is a "top priority," and that it works with companies to address serious quality issues and minimize supply disruptions.

Read the full story:

http://tinyurl.com/7cjwwhn

Source: Reuters

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Carrie Kitko
Merrill H. Stewart, MD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Dr Ibrahim Aldoss
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo